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USE OF BONE PROTECTION IN PATIENTS WITH PRIMARY INTRACRANIAL TUMOURS ON LONG TERM CORTICOSTEROIDS
Background Long term use of corticosteroids can be associated with significant morbidity, including development of glucocorticoid-induced osteoporosis and resultant fractures, leading to increased pain and disability. There are currently no specific standards or guidelines pertaining to the use of bone protection in patients on long term corticosteroids in palliative care. However, given that a significant proportion of palliative care patients are on corticosteroids for prolonged periods, this is an area that should be explored further. Aims . To ascertain current use of bone protection in a palliative cohort of patients with a diagnosis of primary intracranial tumour on long term corticosteroid treatment . To identify patients in this cohort who would likely have benefited from receiving bone protection
Standards Standards used were the American College of Rheumatology 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. These guidelines recommended for this cohort that patients on long term glucocorticoid treatment (dose !7.5 mg prednisolone daily for ! three months) should be on bone protection therapy (bisphosphonate). Methodology Retrospective audit using chart review of patients with primary intracranial tumours on initial referral to Palliative Care Team.
Results Initially 39 eligible patients identified. On manual review of these charts, 32 were eligible, n=32. 37.5% were on steroids on admission, and had been on steroids for > three months on initial assessment and had greater than three months to live. 12.5% had > six months to live and were on steroids on first assessment, and 6.25% had been on >3 month course of steroids. Results The desired standard of 100% completion was used. 43% of documents were signed by the Consultant deciding to use the aPoC with 29% of cases having clear documentation that aPoC was to be used in the medical notes. On average, the standard of completion of the front page was 60%, the recognition of dying section was 61%, previous wishes of the patient 49%, individualised care plan 86%, ongoing medical review 84% and psychological review 42%. Staff questionnaires showed that 40% of staff were not aware of the five priorities of care and 28% were not aware of the aPoC document.
Conclusions Overall, the standard of completion of the document was variable. Some sections were carried out well but others showed significant areas for improvement. Staff questionnaire data suggests that across different staff groups, there is limited knowledge and awareness of the priorities of care. Staff education will therefore be the main implementation strategy prior to a re-audit of the standard of completion of the apoc document. The standard set for all criteria was 100%. . Over the past 3 days, have you been feeling anxious or worried about your illness or treatment? . Have you been feeling depressed?
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AUDIT OF ADHERENCE TO PRESCRIBING STANDARDS AS A MEANS OF IMPROVING PRESCRIBING PRACTICE ON DRUG CHARTS IN A HOSPICE IN-PATIENT UNIT
A separate assessment of Information and Insight was also introduced.
All case notes were re-audited in November 2015. Results 80% of patients had a psychological assessment completed by a doctor but only 35% mentioned mood or anxiety. Most common non-mood or anxiety related comments related to physical symptoms, prognosis or insight.
At re-audit, 100% of patients had a medical psychological assessment and there was a significant decrease in recording of non-mood symptoms. Conclusions Without clear prompts, doctors often made poor assessments focusing on non-mood symptoms like insight or prognosis. Implementing OACC caused significant improvements in psychological assessment of patients by doctors. The change required minimal training. OACC can be a powerful and measurable tool for improving patient assessment.
